Vanderbilt Business Review
  • All Posts
  • Opinion
  • Nashville
  • On Campus
  • Careers
  • Finance
  • World
  • Economy
  • Businesses
  • Technology
  • About Us
  • Newsletter
  • All Posts
  • Opinion
  • Nashville
  • On Campus
  • Careers
  • Finance
  • World
  • Economy
  • Businesses
  • Technology
  • About Us
  • Newsletter
  • Home
  • medicine
GLP-1s: A Game Changer. But for Whom?
10
Nov
By Ava Nalavala
All Posts, Analysis, Economy, Industries, Technologyindustry, medicine, nalavala, ozempic

GLP-1s: A Game Changer. But for Whom?

PeopleImages via iStockPhoto What are GLP-1s? The emergence of GLP-1 drugs as effective treatments for obesity has dominated the recent news. Top headlines from Bloomberg, CNBC, The New York Times, People, and numerous other publications illustrate how this product has quickly become a mainstream part of our culture.  GLP-1, or…
Read More
Vanderbilt Business Review is not operated by Vanderbilt University. The views and opinions expressed in this publication are those of the authors and do not necessarily reflect the policy or position of Vanderbilt University or its official representatives. Vanderbilt® and the Vanderbilt logos are registered trademarks of The Vanderbilt University. © 2025 Vanderbilt University